Abstract

Clonal hematopoiesis (CH)—age-related expansion of mutated hematopoietic clones—can differ in frequency and cellular fitness by CH type (e.g., mutations in driver genes (CHIP), gains/losses and copy-neutral loss of chromosomal segments (mCAs), and loss of sex chromosomes). Co-occurring CH raises questions as to their origin, selection, and impact. We integrate sequence and genotype array data in up to 482,378 UK Biobank participants to demonstrate shared genetic architecture across CH types. Our analysis suggests a cellular evolutionary trade-off between different types of CH, with LOY occurring at lower rates in individuals carrying mutations in established CHIP genes. We observed co-occurrence of CHIP and mCAs with overlap at TET2, DNMT3A, and JAK2, in which CHIP precedes mCA acquisition. Furthermore, individuals carrying overlapping CH had high risk of future lymphoid and myeloid malignancies. Finally, we leverage shared genetic architecture of CH traits to identify 15 novel loci associated with leukemia risk.

Types of clonal hematopoiesis (CH) differ in frequency and fitness. These findings uncover shared genetic architecture, suggest evolutionary trade-offs between CH types, and detail elevated leukemia risk in individuals with overlapping types of CH.

Details

Title
Shared and distinct genetic etiologies for different types of clonal hematopoiesis
Author
Brown, Derek W. 1   VIAFID ORCID Logo  ; Cato, Liam D. 2 ; Zhao, Yajie 3   VIAFID ORCID Logo  ; Nandakumar, Satish K. 4   VIAFID ORCID Logo  ; Bao, Erik L. 2   VIAFID ORCID Logo  ; Gardner, Eugene J. 3 ; Hubbard, Aubrey K. 5 ; DePaulis, Alexander 5 ; Rehling, Thomas 5 ; Song, Lei 5 ; Yu, Kai 5 ; Chanock, Stephen J. 5   VIAFID ORCID Logo  ; Perry, John R. B. 6   VIAFID ORCID Logo  ; Sankaran, Vijay G. 2   VIAFID ORCID Logo  ; Machiela, Mitchell J. 5   VIAFID ORCID Logo 

 National Cancer Institute, Division of Cancer Epidemiology and Genetics, Rockville, USA (GRID:grid.48336.3a) (ISNI:0000 0004 1936 8075); National Cancer Institute, Cancer Prevention Fellowship Program, Division of Cancer Prevention, Rockville, USA (GRID:grid.48336.3a) (ISNI:0000 0004 1936 8075) 
 Dana-Farber Cancer Institute, Harvard Medical School, Division of Hematology/Oncology, Boston Children’s Hospital and Department of Pediatric Oncology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34) 
 University of Cambridge School of Clinical Medicine, MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
 Dana-Farber Cancer Institute, Harvard Medical School, Division of Hematology/Oncology, Boston Children’s Hospital and Department of Pediatric Oncology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34); Albert Einstein Cancer Center, Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Department of Cell Biology, Albert Einstein College of Medicine, Bronx, USA (GRID:grid.516102.1) (ISNI:0000 0004 1799 294X) 
 National Cancer Institute, Division of Cancer Epidemiology and Genetics, Rockville, USA (GRID:grid.48336.3a) (ISNI:0000 0004 1936 8075) 
 University of Cambridge School of Clinical Medicine, MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge School of Clinical Medicine, Metabolic Research Laboratory, Wellcome-MRC Institute of Metabolic Science, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
Pages
5536
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2862609870
Copyright
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.